Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist Aleix Cases;

Response to ¿Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis¿. Response to related letter José C. De La Flor; Esperanza Moral; Javier Deira; Tania Monzón; Francisco Valga; Cristina Albarracín; Miguel Rodeles;

A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study Sheila Bermejo; Ester González; Katia López-Revuelta; Meritxell Ibernon; Diana López; Adoración Martín-Gómez; Rosa Garcia-Osuna; Tania Linares; Montserrat Díaz; Nàdia Martín; Xoana Barros; Helena Marco; Maruja Isabel Navarro; Noemí Esparza; Sandra Elias; Ana Coloma; Nicolás Roberto Robles; Irene Agraz; Esteban Poch; Lida Rodas; Víctor Lozano; Beatriz Fernández-Fernández; Eduardo Hernández; Maria Isabel Martínez; Ramona Ionela Stanescu; José Pelayo Moirón; Núria García-Fernández; Marian Goicoechea; Francesca Calero; Josep Bonet; Fernando Liaño; Julio Pascual; Manuel Praga; Xavier Fulladosa; María José Soler;